Actively Recruiting Studies


If you think you may qualify for one of these studies, please contact Neurology Research at (303) 724-4644 or



COMIRB #Title (Please click on the title to see approved advertisement)Principal InvestigatorEligibility and InformationAdvertisement
17-2334AMPLATZERTM PFO Occluder Post Approval StudyKaren Orjuela, MDClinical TrialsN/A
19-0675Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction (CHARM)Sharon Poisson, MDClinical TrialsN/A